Nina Shah, MD, and other experts discuss the role of CAR T-cell therapy in relapsed/refractory multiple myeloma.
Sagar Lonial, MD, FACP
Advertisement
Articles by Sagar Lonial, MD, FACP
Sagar Lonial, MD, FACP, discusses the development of bispecific T-cell engagers (BiTEs) and CAR T-cell therapy in multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Lonial Discusses Ongoing Research With BiTEs and CAR T-Cell Therapy in MyelomaPublished: October 6th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
2
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
3
Key Unknowns Remain in Cell and Gene Therapy
4
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
5
